05:38 PM EDT, 10/08/2025 (MT Newswires) -- Ivan Hyep, Chief Financial Officer, on October 06, 2025, sold 30,385 shares in Bicara Therapeutics ( BCAX ) for $553,198. Following the Form 4 filing with the SEC, Hyep has control over a total of 145,355 common shares of the company, with 145,355 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/2023658/000203466825000004/xslF345X05/wk-form4_1759959228.xml